Bibliografia generale
N.d.R: alla fine di ogni capitolo sono state inserite le note bibliografiche. In questa sezione, per maggiore comodità del lettore, vengono riportate le stesse in ordine alfabetico, in base alla tipologia dell’opera consultata.
Testi consultati:
1. Ancillotti M. La riforma del codice della strada. La nuova disciplina dopo la legge 120/2010: Maggioli Editore; 2010.
2. Cassano GB, Tundo A. Psicopatologia e clinica psichiatrica: Utet; 2010.
3. Federici F, BErnardini S, Bertoli A, Cipriani P, Cortese C, Fusco A, et al. Medicina di laboratorio: Mc Graw Hill; 2003.
4. Fucci N, Giovanni ND. Il laboratorio di tossicologia forense: Selecta Medica; 2007.
5. Henry JB. Diagnosi clinica e metodi di laboratorio: Antonio Delfino editore; 2004.
6. Macchiarelli L, Arbarello P, Bondi GC, Luca NMd, Feola T. Medicina Legale: Edizioni Minerva medica; 2008.
7. Moffat AC, Osselton MD, Widdop B. Clarke's Analysis of Drugs and Poisons:
Pharmaceutical Press; 2004.
8. Norelli GA, Buccelli C, Fineschi V. Medicina legale e delle assicurazioni: Piccin; 2009.
9. Riccardi G. Reati alla guida. Percorsi giurisprudenziali: Giuffrè Editore; 2010.
10. Rinaldi M. La guida sotto l'effetto di alcol e stupefacenti. L'accertamento e il processo. Con 49 formule e sentenze per argomento.: Maggioli editore; 2012.
Leggi e sentenze consultate:
1. Art. 119 del Nuovo Codice della Strada "Requisiti fisici e psichici per il conseguimento della patente". 2010.
2. Art. 186 del Nuovo Codice della Strada "Guida sotto l'influenza dell'alcool ". 2010.
3. Articolo 186 bis del Nuovo Codice della Strada "Guida sotto l'influenza dell'alcool per conducenti di età inferiore a ventuno anni, per i neo-patentati e per chi esercita professionalmente l'attività di trasporto di persone o di cose".
4. Art. 187 del Nuovo Codice della Strada "Guida in stato di alterazione psico-fisica per uso di sostanze stupefacenti". 2010.
5. Art. 230 del Nuovo Codice dela strada "Educazione stradale".
6. Regolamento di esecuzione e di attuazione del nuovo codice della strada. D.P.R. 16/12/92 n.495.
7. Art. 359 bis del Codice di Procedura Penale "Prelievo coattivo di campioni biologici".
8. Cassazione Penale, sez. IV, 11 agosto 2008, n° 33312.
9. Cassazione Penale, sezione IV, 26 ottobre 2011 n.38793
Articoli consultati:
1. Adebayo A. Factors antecedent to impaired driving in a Canadian urban sample. Int J Addict.
1991; 26(8): 897-909.
2. Agius R, Nadulski T, Kahl HG, Dufaux B. Significantly increased detection rate of drugs of abuse in urine following the introduction of new German driving licence re-granting guidelines.
Forensic Sci Int. 2012; 215(1-3): 32-7.
3. Agius R, Nadulski T, Moore C. Validation of LUCIO-Direct-ELISA kits for the detection of drugs of abuse in urine: application to the new German driving licence re-granting guidelines.
Forensic Sci Int. 2012; 215(1-3): 38-45.
4. Albermann ME, Musshoff F, Madea B. A fully validated high-performance liquid chromatography-tandem mass spectrometry method for the determination of ethyl glucuronide in hair for the proof of strict alcohol abstinence. Anal Bioanal Chem. 2010; 396(7): 2441-7.
5. Aldenhovel HG. [Increased serum activities of gamma-GT and transaminases within the framework of medical suitability studies of automobile drivers with alcohol-related incidents: some aspects of differential diagnosis]. Blutalkohol. 1984; 21(6): 471-8.
6. Aldenhovel HG. [Gamma-glutamyl-transpeptidase and transaminases in the sera of drunk drivers--some empirical findings]. Blutalkohol. 1985; 22(4): 290-7.
7. Alha A, Honkanen R, Karlsson M, Laiho K, Linnoila M, Lukkari I. Practical aspects of the routine measurement of alcohol and drugs in drivers. A preliminary report. Mod Probl Pharmacopsychiatry. 1976; 11: 42-5.
8. Allen AJ, Meda SA, Skudlarski P, Calhoun VD, Astur R, Ruopp KC, et al. Effects of alcohol on performance on a distraction task during simulated driving. Alcohol Clin Exp Res. 2009;
33(4): 617-25.
9. Alvarez FJ, Fierro I, Del Rio MC. Cannabis and driving: results from a general population survey. Forensic Sci Int. 2007; 170(2-3): 111-6.
10. Anderson P, Chisholm D, Fuhr DC. Effectiveness and cost-effectiveness of policies and programmes to reduce the harm caused by alcohol. Lancet. 2009; 373(9682): 2234-46.
11. Anton RF. Carbohydrate-deficient transferrin for detection and monitoring of sustained heavy drinking. What have we learned? Where do we go from here? Alcohol. 2001; 25(3): 185-8.
12. Appenzeller BM, Schneider S, Maul A, Wennig R. Relationship between blood alcohol concentration and carbohydrate-deficient transferrin among drivers. Drug Alcohol Depend. 2005;
79(2): 261-5.
13. Appenzeller BM, Schneider S, Yegles M, Maul A, Wennig R. Drugs and chronic alcohol abuse in drivers. Forensic Sci Int. 2005; 155(2-3): 83-90.
14. Asbridge M, Poulin C, Donato A. Motor vehicle collision risk and driving under the influence of cannabis: evidence from adolescents in Atlantic Canada. Accid Anal Prev. 2005; 37(6):
1025-34.
15. Augsburger M, Donze N, Menetrey A, Brossard C, Sporkert F, Giroud C, et al.
Concentration of drugs in blood of suspected impaired drivers. Forensic Sci Int. 2005; 153(1): 11-5.
16. Bachs L, Hoiseth G, Skurtveit S, Morland J. Heroin-using drivers: importance of morphine and morphine-6-glucuronide on late clinical impairment. Eur J Clin Pharmacol. 2006; 62(11): 905- 12.
17. Barrett PR, Horne JA, Reyner LA. Alcohol continues to affect sleepiness related driving impairment, when breath alcohol levels have fallen to near-zero. Hum Psychopharmacol. 2004;
19(6): 421-3.
18. Bartl G, Lager F, Domesle L. [Test performance with minimal alcoholic intoxication].
Blutalkohol. 1996; 33(1): 1-16.
19. Barz J, Bonte W, Keultjes C, Sieland J. Concentrations of ethanol, methanol, propanol-2 and acetone in blood samples of impaired drivers. Acta Med Leg Soc (Liege). 1990; 40: 49-60.
20. Bedard M, Dubois S, Weaver B. The impact of cannabis on driving. Can J Public Health.
2007; 98(1): 6-11.
21. Bernosky-Smith KA, Aston ER, Liguori A. Rapid drinking is associated with increases in driving-related risk-taking. Hum Psychopharmacol. 2012.
22. Berzlanovich A, Muhm M, Bauer G. [The value of breath alcohol determination in street traffic]. Beitr Gerichtl Med. 1992; 50: 229-34.
23. Bianchi V, Ivaldi A, Raspagni A, Arfini C, Vidali M. Use of carbohydrate-deficient transferrin (CDT) and a combination of GGT and CDT (GGT-CDT) to assess heavy alcohol consumption in traffic medicine. Alcohol Alcohol. 2010; 45(3): 247-51.
24. Bingham CR, Shope JT, Zhu J. Substance-involved driving: predicting driving after using alcohol, marijuana, and other drugs. Traffic Inj Prev. 2008; 9(6): 515-26.
25. Birdsall WC, Reed BG, Huq SS, Wheeler L, Rush S. Alcohol-impaired driving: average quantity consumed and frequency of drinking do matter. Traffic Inj Prev. 2012; 13(1): 24-30.
26. Blencowe T, Pehrsson A, Mykkanen S, Gunnar T, Lillsunde P. Cannabis findings in drivers suspected of driving under the influence of drugs in Finland from 2006 to 2008. Forensic Sci Int.
2012; 217(1-3): 107-12.
27. Blume SB. Gender differences in alcohol-related disorders. Harv Rev Psychiatry. 1994;
2(1): 7-14.
28. Bortolotti F, Trettene M, Gottardo R, Bernini M, Ricossa MC, Tagliaro F. Carbohydrate- deficient transferrin (CDT): a reliable indicator of the risk of driving under the influence of alcohol when determined by capillary electrophoresis. Forensic Sci Int. 2007; 170(2-3): 175-8.
29. Bowden KM. Driving under the influence of alcohol. J Forensic Med. 1966; 13(2): 44-67.
30. Bramness JG, Skurtveit S, Gustavsen I, Morland J. The absence of evidence is not the same as evidence for absence! Addiction. 2008; 103(3): 513-4.
31. Brick J, Erickson CK. Intoxication Is Not Always Visible: An Unrecognized Prevention Challenge. Alcohol Clin Exp Res. 2009; 33(9): 1489-507.
32. Brookhuis KA, De Waard D, Fairclough SH. Criteria for driver impairment. Ergonomics.
2003; 46(5): 433-45.
33. Brookoff D, Cook CS, Williams C, Mann CS. Testing reckless drivers for cocaine and marijuana. N Engl J Med. 1994; 331(8): 518-22.
34. Brown TG, Ouimet MC, Nadeau L, Gianoulakis C, Lepage M, Tremblay J, et al. From the brain to bad behaviour and back again: neurocognitive and psychobiological mechanisms of driving while impaired by alcohol. Drug Alcohol Rev. 2009; 28(4): 406-18.
35. Buchan BJ, Walsh JM, Leaverton PE. Evaluation of the accuracy of on-site multi-analyte drug testing devices in the determination of the prevalence of illicit drugs in drivers. J Forensic Sci.
1998; 43(2): 395-9.
36. Burns CR. Blood alcohol levels and alcoholism. N Z Med J. 1972; 75(477): 120.
37. Calhoun VD, Pearlson GD. A selective review of simulated driving studies: Combining naturalistic and hybrid paradigms, analysis approaches, and future directions. NeuroImage. 2012;
59(1): 25-35.
38. Calhoun VD, Pekar JJ, Pearlson GD. Alcohol intoxication effects on simulated driving:
exploring alcohol-dose effects on brain activation using functional MRI.
Neuropsychopharmacology. 2004; 29(11): 2097-17.
39. Cami J, Farre M, Gonzalez ML, Segura J, de la Torre R. Cocaine metabolism in humans after use of alcohol. Clinical and research implications. Recent Dev Alcohol. 1998; 14: 437-55.
40. Ceder G, Jones AW. Concentration ratios of morphine to codeine in blood of impaired drivers as evidence of heroin use and not medication with codeine. Clin Chem. 2001; 47(11): 1980- 4.
41. Chanarin I. Alcohol and the blood. Br J Haematol. 1979; 42(3): 333-6.
42. Cherpitel CJ, Ye Y, Greenfield TK, Bond J, Kerr WC, Midanik LT. Alcohol-related injury and driving while intoxicated: a risk function analysis of two alcohol-related events in the 2000 and 2005 National Alcohol Surveys. Am J Drug Alcohol Abuse. 2010; 36(3): 168-74.
43. Chiarotti M, De Giovanni N, Bertol E, Centini F, Froldi R, Groppi A, et al. Breath alcohol analysis: interlaboratory evaluation of silica gel as trapping system. Blutalkohol. 1987; 24(5): 310-5.
44. Christophersen AS, Gjerde H, Bjorneboe A, Sakshaug J, Morland J. Screening for drug use among Norwegian drivers suspected of driving under influence of alcohol or drugs. Forensic Sci Int.
45. Chu M, Gerostamoulos D, Beyer J, Rodda L, Boorman M, Drummer OH. The incidence of drugs of impairment in oral fluid from random roadside testing. Forensic Sci Int. 2012; 215(1-3):
28-31.
46. Clardy DO. Population pharmacokinetics of ethanol in drinking drivers using breath measures. Ther Drug Monit. 2004; 26(4): 391-400.
47. Couture S, Brown TG, Tremblay J, Ng Ying Kin NM, Ouimet MC, Nadeau L. Are biomarkers of chronic alcohol misuse useful in the assessment of DWI recidivism status? Accid Anal Prev. 2010; 42(1): 307-12.
48. Crouch DJ, Peat MA, Chinn DM, Finkle BS. Drugs and driving: a systematic analytical approach. J Forensic Sci. 1983; 28(4): 945-56.
49. Crouch DJ, Walsh JM, Cangianelli L, Quintela O. Laboratory evaluation and field application of roadside oral fluid collectors and drug testing devices. Ther Drug Monit. 2008; 30(2):
188-95.
50. Davey J, Freeman J. Screening for drugs in oral fluid: drug driving and illicit drug use in a sample of Queensland motorists. Traffic Inj Prev. 2009; 10(3): 231-6.
51. Davey J, Leal N, Freeman J. Screening for drugs in oral fluid: illicit drug use and drug driving in a sample of Queensland motorists. Drug Alcohol Rev. 2007; 26(3): 301-7.
52. Delile JM. [Use of cannabis: screening strategy and evaluation of severity factors]. Rev Prat.
2005; 55(1): 51-63.
53. Drummer OH. Introduction and review of collection techniques and applications of drug testing of oral fluid. Ther Drug Monit. 2008; 30(2): 203-6.
54. Dussault C, Brault M, Lemire AM, Bouchard J. The role of cocaine in fatal crashes: first results of the Quebec drug study. Annu Proc Assoc Adv Automot Med. 2001; 45: 125-37.
55. Evans RT. Alcohol and drink driving in the United Kingdom. Arh Hig Rada Toksikol. 2005;
56(4): 373-8.
56. Farrell LJ, Kerrigan S, Logan BK. Recommendations for toxicological investigation of drug impaired driving. J Forensic Sci. 2007; 52(5): 1214-8.
57. Fell JC, Tippetts AS, Voas RB. Fatal traffic crashes involving drinking drivers: what have we learned? Ann Adv Automot Med. 2009; 53: 63-76.
58. Fergusson DM, Horwood LJ, Boden JM. Is driving under the influence of cannabis becoming a greater risk to driver safety than drink driving? Findings from a longitudinal study.
Accid Anal Prev. 2008; 40(4): 1345-50.
59. Fine EW, Scoles P, Mulligan M. Under the influence. Public Health Rep. 1975; 90(5): 424-9.
60. Fransson M, Jones AW, Andersson L. Laboratory evaluation of a new evidential breath- alcohol analyser designed for mobile testing--the Evidenzer. Med Sci Law. 2005; 45(1): 61-70.
61. Furr-Holden CD, Voas RB, Lacey J, Romano E, Jones K. The prevalence of alcohol use disorders among night-time weekend drivers. Addiction. 2011; 106(7): 1251-60.
62. Garriott JC, Latman N. Drug detection in cases of "driving under the influence". J Forensic Sci. 1976; 21(2): 398-415.
63. Gjerde H, Christophersen AS, Normann PT, Morland J. Toxicological investigations of drivers killed in road traffic accidents in Norway during 2006-2008. Forensic Sci Int. 2011; 212(1- 3): 102-9.
64. Gjerde H, Christophersen AS, Normann PT, Pettersen BS, Sabaredzovic A, Samuelsen SO, et al. Analysis of alcohol and drugs in oral fluid from truck drivers in Norway. Traffic Inj Prev.
2012; 13(1): 43-8.
65. Gough TA, Baker PB. Identification of major drugs of abuse using chromatography: an update. J Chromatogr Sci. 1983; 21(4): 145-53.
66. Gronholm M, Lillsunde P. A comparison between on-site immunoassay drug-testing devices and laboratory results. Forensic Sci Int. 2001; 121(1-2): 37-46.
67. GTFI. Linee guida per i laboratori di analisi di sostanze d’abuso con finalità tossicologico-
2012 a cura della Commissione Qualità delìAssociazione scientifica "Gruppo Tossicologi Forensi Italiani (GTFI)". In: Italiani GTF, editor.; 2012.
68. Gustavsen I, Morland J, Bramness JG. Impairment related to blood amphetamine and/or methamphetamine concentrations in suspected drugged drivers. Accid Anal Prev. 2006; 38(3): 490- 5.
69. Hall W, Babor TF. Cannabis use and public health: assessing the burden. Addiction. 2000;
95(4): 485-90.
70. Heishman SJ, Singleton EG, Crouch DJ. Laboratory validation study of drug evaluation and classification program: alprazolam, d-amphetamine, codeine, and marijuana. J Anal Toxicol. 1998;
22(6): 503-14.
71. Hingson R, Winter M. Epidemiology and consequences of drinking and driving. Alcohol Res Health. 2003; 27(1): 63-78.
72. Hollister LE. Cannabis--1988. Acta Psychiatr Scand Suppl. 1988; 345: 108-18.
73. Huestis MA, Verstraete A, Kwong TC, Morland J, Vincent MJ, de la Torre R. Oral fluid testing: promises and pitfalls. Clin Chem. 2011; 57(6): 805-10.
74. Isaksson A, Walther L, Hansson T, Andersson A, Alling C. Phosphatidylethanol in blood (B-PEth): a marker for alcohol use and abuse. Drug Test Anal. 2011; 3(4): 195-200.
75. Ivers RQ, Blows SJ, Stevenson MR, Norton RN, Williamson A, Eisenbruch M, et al. A cohort study of 20,822 young drivers: the DRIVE study methods and population. Inj Prev. 2006;
12(6): 385-9.
76. Jatlow P. Cocaine: Analysis, Pharmacokinetics, and Metabolic Disposition. The Yale journal of Biology and Medicine. 1988; 61: 105-13.
77. Jones AW. Heroin use by motorists in Sweden confirmed by analysis of 6-acetylmorphine in urine. J Anal Toxicol. 2001; 25(5): 353-5.
78. Jones AW. Age- and gender-related differences in blood amphetamine concentrations in apprehended drivers: lack of association with clinical evidence of impairment. Addiction. 2007;
102(7): 1085-91.
79. Jones AW, Andersson L. Variability of the blood/breath alcohol ratio in drinking drivers. J Forensic Sci. 1996; 41(6): 916-21.
80. Jones AW, Fransson M. Blood analysis by headspace gas chromatography: does a deficient sample volume distort ethanol concentration? Med Sci Law. 2003; 43(3): 241-7.
81. Jones AW, Holmgren A. Abnormally high concentrations of amphetamine in blood of impaired drivers. J Forensic Sci. 2005; 50(5): 1215-20.
82. Jones AW, Holmgren A, Kugelberg FC. Concentrations of cocaine and its major metabolite benzoylecgonine in blood samples from apprehended drivers in Sweden. Forensic Sci Int. 2008;
177(2-3): 133-9.
83. Jones AW, Schuberth J. Computer-aided headspace gas chromatography applied to blood- alcohol analysis: importance of online process control. J Forensic Sci. 1989; 34(5): 1116-27.
84. Kalant H. Adverse effects of cannabis on health: an update of the literature since 1996. Prog Neuropsychopharmacol Biol Psychiatry. 2004; 28(5): 849-63.
85. Kelly E, Darke S, Ross J. A review of drug use and driving: epidemiology, impairment, risk factors and risk perceptions. Drug Alcohol Rev. 2004; 23(3): 319-44.
86. Khiabani HZ, Bramness JG, Bjorneboe A, Morland J. Relationship between THC concentration in blood and impairment in apprehended drivers. Traffic Inj Prev. 2006; 7(2): 111-6.
87. Kintz P, Cirimele V, Ludes B. Detection of cannabis in oral fluid (saliva) and forehead wipes (sweat) from impaired drivers. J Anal Toxicol. 2000; 24(7): 557-61.
88. Kuhns JB, Wilson DB, Maguire ER, Ainsworth SA, Clodfelter TA. A meta-analysis of marijuana, cocaine and opiate toxicology study findings among homicide victims. Addiction. 2009;
104(7): 1122-31.
89. Langford NJ, Ferner RE. The medico-legal significance of pharmacokinetic interactions
90. Lemos NP. Methamphetamine and driving. Sci Justice. 2009; 49(4): 247-9.
91. Lillsunde P. Analytical techniques for drug detection in oral fluid. Ther Drug Monit. 2008;
30(2): 181-7.
92. Lillsunde P, Michelson L, Forsstrom T, Korte T, Schultz E, Ariniemi K, et al.
Comprehensive drug screening in blood for detecting abused drugs or drugs potentially hazardous for traffic safety. Forensic Sci Int. 1996; 77(3): 191-210.
93. Liu YC, Fu SM. Changes in driving behavior and cognitive performance with different breath alcohol concentration levels. Traffic Inj Prev. 2007; 8(2): 153-61.
94. Logan BH, Gullberg EG. Alcohol, Drugs and Driving. In: Moffat AC, Osselton MD, Widdop B, editors. Clarke's Analysis of Drugs and Poisons; 2004. p. 53-67.
95. Logan BK. Methamphetamine and driving impairment. J Forensic Sci. 1996; 41(3): 457-64.
96. MacDonald S, Mann R, Chipman M, Pakula B, Erickson P, Hathaway A, et al. Driving behavior under the influence of cannabis or cocaine. Traffic Inj Prev. 2008; 9(3): 190-4.
97. Mahdy T, El-Shihi TH, Emara MM, Chericoni S, Giusiani M, Giorgi M. Development and Validation of a New GC–MS Method for the Detection of Tramadol, O-Desmethyltramadol, 6- Acetylmorphine and Morphine in Blood, Brain, Liver and Kidney of Wistar Rats Treated with the Combination of Heroin and Tramadol. Journal of Analytical Toxicology. 2012; 36(8): 548-59.
98. Maskalyk J. Drinking and driving. CMAJ. 2003; 168(3): 313.
99. Mason MF, Dubowski KM. Breath-alcohol analysis: uses, methods, and some forensic problems--review and opinion. J Forensic Sci. 1976; 21(1): 9-41.
100. Morris MJ. Alcohol breath testing in patients with respiratory disease. Thorax. 1990; 45(10):
717-21.
101. Musshoff F, Madea B. Review of biologic matrices (urine, blood, hair) as indicators of recent or ongoing cannabis use. Ther Drug Monit. 2006; 28(2): 155-63.
102. Musshoff F, Madea B. Cocaine and benzoylecgonine concentrations in fluorinated plasma samples of drivers under suspicion of driving under influence. Forensic Sci Int. 2010; 200(1-3): 67- 72.
103. Musshoff F, Madea B. Driving under the influence of amphetamine-like drugs. J Forensic Sci. 2012; 57(2): 413-9.
104. Neuteboom W, Jones AW. Disappearance rate of alcohol from the blood of drunk drivers calculated from two consecutive samples; what do the results really mean? Forensic Sci Int. 1990;
45(1-2): 107-15.
105. Ogundipe KA, Weiss KJ. Drunk driving, implied consent, and self-incrimination. J Am Acad Psychiatry Law. 2009; 37(3): 386-91.
106. Payne JP. Gas chromatography. Alcohol in blood and urine. Proc R Soc Med. 1968; 61(5):
530-4.
107. Peel HW, Perrigo BJ, Mikhael NZ. Detection of drugs in saliva of impaired drivers. J Forensic Sci. 1984; 29(1): 185-9.
108. Pehrsson A, Gunnar T, Engblom C, Seppa H, Jama A, Lillsunde P. Roadside oral fluid testing: comparison of the results of drugwipe 5 and drugwipe benzodiazepines on-site tests with laboratory confirmation results of oral fluid and whole blood. Forensic Sci Int. 2008; 175(2-3): 140- 8.
109. Peters FT, Samyn N, Kraemer T, Riedel WJ, Maurer HH. Negative-ion chemical ionization gas chromatography-mass spectrometry assay for enantioselective measurement of amphetamines in oral fluid: application to a controlled study with MDMA and driving under the influence cases.
Clin Chem. 2007; 53(4): 702-10.
110. Pil K, Verstraete A. Current developments in drug testing in oral fluid. Ther Drug Monit.
2008; 30(2): 196-202.
111. Polla M, Stramesi C, Pichini S, Palmi I, Vignali C, Dall'Olio G. Hair testing is superior to urine to disclose cocaine consumption in driver's licence regranting. Forensic Sci Int. 2009; 189(1-
112. Richer I, Bergeron J. Driving under the influence of cannabis: links with dangerous driving, psychological predictors, and accident involvement. Accid Anal Prev. 2009; 41(2): 299-307.
113. Ricossa MC, Bernini M, F DEF. Hair analysis for driving licence in cocaine and heroin users. An epidemiological study. Forensic Sci Int. 2000; 107(1-3): 301-8.
114. Root I. Drugs of abuse and fatal automobile accidents. Leg Med. 1989: 25-38.
115. Rubenzer S. Judging intoxication. Behav Sci Law. 2011; 29(1): 116-37.
116. Samyn N, van Haeren C. On-site testing of saliva and sweat with Drugwipe and determination of concentrations of drugs of abuse in saliva, plasma and urine of suspected users. Int J Legal Med. 2000; 113(3): 150-4.
117. Schechtman E, Shinar D. Modeling drug detection and diagnosis with the 'drug evaluation and classification program'. Accid Anal Prev. 2005; 37(5): 852-61.
118. Schepers RJ, Oyler JM, Joseph RE, al. E. Methamphetamine and amphetamine pharmacokinetics in oral fluid and plasma after controlled oral methamphetamine administration to human volunteers. . Clin Chem. 2003; 49: 121-32.
119. Schulz K, Bertau M, Schlenz K, Malt S, Dressler J, Lachenmeier DW. Headspace solid- phase microextraction-gas chromatography-mass spectrometry determination of the characteristic flavourings menthone, isomenthone, neomenthol and menthol in serum samples with and without enzymatic cleavage to validate post-offence alcohol drinking claims. Anal Chim Acta. 2009; 646(1- 2): 128-40.
120. Silber BY, Croft RJ, Downey LA, Papafotiou K, Camfield DA, Stough C. The effect of d- methamphetamine on simulated driving performance. Hum Psychopharmacol. 2012; 27(2): 139-44.
121. Silber BY, Croft RJ, Papafotiou K, Stough C. The acute effects of d-amphetamine and methamphetamine on attention and psychomotor performance. Psychopharmacology (Berl). 2006;
187(2): 154-69.
122. Siliquini R, Chiado Piat S, Gianino MM, Renga G. Drivers involved in road traffic accidents in Piedmont Region: psychoactive substances consumption. J Prev Med Hyg. 2007; 48(4): 123-8.
123. Stoduto G, Mann RE, Ialomiteanu A, Wickens CM, Brands B. Examining the link between collision involvement and cocaine use. Drug Alcohol Depend. 2012; 123(1-3): 260-3.
124. Sutton LR, Paegle I. The drug impaired driver. Detection and forensic specimen analysis.
Blutalkohol. 1992; 29(2): 134-8.
125. Tagliaro F, Valentini R, Manetto G, Crivellente F, Carli G, Marigo M. Hair analysis by using radioimmunoassay, high-performance liquid chromatography and capillary electrophoresis to investigate chronic exposure to heroin, cocaine and/or ecstasy in applicants for driving licences.
Forensic Sci Int. 2000; 107(1-3): 121-8.
126. Teixeira H, Proenca P, Castanheira A, Santos S, Lopez-Rivadulla M, Corte-Real F, et al.
Cannabis and driving: the use of LC-MS to detect delta9-tetrahydrocannabinol (delta9-THC) in oral fluid samples. Forensic Sci Int. 2004; 146 Suppl: S61-3.
127. Van der Linden T, Legrand SA, Silverans P, Verstraete AG. DUID: oral fluid and blood confirmation compared in Belgium. J Anal Toxicol. 2012; 36(6): 418-21.
128. Verstraete AG. Oral fluid testing for driving under the influence of drugs: history, recent progress and remaining challenges. Forensic Sci Int. 2005; 150(2-3): 143-50.
129. Wille SM, Raes E, Lillsunde P, Gunnar T, Laloup M, Samyn N, et al. Relationship between oral fluid and blood concentrations of drugs of abuse in drivers suspected of driving under the influence of drugs. Ther Drug Monit. 2009; 31(4): 511-9.
